Tissue‐type plasminogen activator deficiency exacerbates cholestatic liver injury in mice
Hongtao Wang, Yan Zhang, Robert O. Heuckeroth – 30 May 2007 – Recent studies demonstrating a role for plasminogen activator inhibitor (PAI)‐1 in cholestatic liver disease in mice suggested that tissue‐type plasminogen activator (tPA) or urokinase plasminogen activator (uPA) might be important after biliary tract obstruction. We now demonstrate that blocking tPA exacerbates liver injury after bile duct ligation (BDL).